Skip to main content

Table 5 AEs and drug-related AEs

From: Effectiveness of combination therapy with nifedipine GITS: a prospective, 12-week observational study (AdADOSE)

 

AEs

Drug-related AEs

Total, patients (%); n = 4477

142 (3.2)

114 (2.6)

Peripheral edema, n (%)

54 (1.2)

48 (1.1)

Headache, n (%)

28 (0.6)

26 (0.6)

Edema, n (%)

15 (0.3)

9 (0.2)

Palpitations, n (%)

11 (0.3)

9 (0.2)

Flushing, n (%)

10 (0.2)

10 (0.2)

Constipation, n (%)

5 (0.1)

5 (0.1)

Dizziness, n (%)

5 (0.1)

5 (0.1)

  1. Incidence of AEs and drug-related AEs (≥0.1 % incidence) in patients during treatment with nifedipine GITS in combination with other antihypertensive agents
  2. AEs adverse events, GITS gastrointestinal therapeutic system